PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Matinas BioPharma Holdings, Inc.
Filed: September 11, 2015
Period of Report: October 29, 2015
Accession Number: 0001626129-15-000203

View Document ↗ View on SEC.gov ↗